TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 141 filers reported holding TG THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $5,972,127 | -16.0% | 504,829 | -58.0% | 0.31% | -25.1% |
Q3 2022 | $7,109,000 | +75.9% | 1,200,813 | +26.3% | 0.41% | +74.9% |
Q2 2022 | $4,041,000 | +29.5% | 950,813 | +189.7% | 0.24% | +132.7% |
Q1 2022 | $3,121,000 | +160.5% | 328,187 | +1325.1% | 0.10% | +129.5% |
Q4 2020 | $1,198,000 | -56.5% | 23,029 | -83.7% | 0.04% | -83.4% |
Q2 2020 | $2,754,000 | +56.4% | 141,364 | -21.0% | 0.26% | +26.8% |
Q1 2020 | $1,761,000 | -42.9% | 178,964 | -35.5% | 0.21% | -22.9% |
Q4 2019 | $3,082,000 | +54.7% | 277,639 | -21.7% | 0.27% | -20.3% |
Q3 2019 | $1,992,000 | -35.1% | 354,719 | 0.0% | 0.34% | -27.0% |
Q2 2019 | $3,068,000 | +490.0% | 354,719 | +448.1% | 0.47% | +529.7% |
Q1 2019 | $520,000 | -21.0% | 64,719 | +29.4% | 0.07% | -72.0% |
Q2 2018 | $658,000 | -7.3% | 50,000 | 0.0% | 0.26% | -37.0% |
Q1 2018 | $710,000 | – | 50,000 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |